Unknown

Dataset Information

0

Effect of IBD medications on COVID-19 outcomes: results from an international registry.


ABSTRACT:

Objective

We sought to evaluate COVID-19 clinical course in patients with IBD treated with different medication classes and combinations.

Design

Surveillance Epidemiology of Coronavirus Under Research Exclusion for Inflammatory Bowel Disease (SECURE-IBD) is a large, international registry created to monitor outcomes of IBD patients with confirmed COVID-19. We used multivariable regression with a generalised estimating equation accounting for country as a random effect to analyse the association of different medication classes with severe COVID-19, defined as intensive care unit admission, ventilator use and/or death.

Results

1439 cases from 47 countries were included (mean age 44.1 years, 51.4% men) of whom 112 patients (7.8%) had severe COVID-19. Compared with tumour necrosis factor (TNF) antagonist monotherapy, thiopurine monotherapy (adjusted OR (aOR) 4.08, 95% CI 1.73 to 9.61) and combination therapy with TNF antagonist and thiopurine (aOR 4.01, 95% CI 1.65 to 9.78) were associated with an increased risk of severe COVID-19. Any mesalamine/sulfasalazine compared with no mesalamine/sulfasalazine use was associated with an increased risk (aOR 1.70, 95% CI 1.26 to 2.29). This risk estimate increased when using TNF antagonist monotherapy as a reference group (aOR 3.52, 95% CI 1.93 to 6.45). Interleukin-12/23 and integrin antagonists were not associated with significantly different risk than TNF antagonist monotherapy (aOR 0.98, 95% CI 0.12 to 8.06 and aOR 2.42, 95% CI 0.59 to 9.96, respectively).

Conclusion

Combination therapy and thiopurines may be associated with an increased risk of severe COVID-19. No significant differences were observed when comparing classes of biologicals. These findings warrant confirmation in large population-based cohorts.MKH should be changed to MDK for co-last author line.

SUBMITTER: Ungaro RC 

PROVIDER: S-EPMC8136807 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC8447321 | biostudies-literature
| S-EPMC8083188 | biostudies-literature
| S-EPMC8047303 | biostudies-literature
| S-EPMC8480964 | biostudies-literature
| S-EPMC7801187 | biostudies-literature
| S-EPMC7292610 | biostudies-literature
| S-EPMC7510540 | biostudies-literature
| S-EPMC7833801 | biostudies-literature
| S-EPMC8128002 | biostudies-literature